Vildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 Diabetes
NCT00237237
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
588
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
vildagliptin
Sponsor
Novartis